Geographically-weighted regression analysis of percentage of late-stage prostate cancer diagnosis in Florida

被引:28
|
作者
Goovaerts, Pierre [1 ]
Xiao, Hong [2 ]
Adunlin, Georges [2 ]
Ali, Askal [2 ]
Tan, Fei [3 ]
Gwede, Clement K. [4 ]
Huang, Youjie [5 ]
机构
[1] BioMedware Inc, Ann Arbor, MI 48104 USA
[2] Univ Florida, Gainesville, FL USA
[3] Indiana Univ Purdue Univ, Indianapolis, IN 46202 USA
[4] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[5] Florida Dept Hlth, Tallahassee, FL USA
关键词
Logistic regression; Cancer; Contextual factors; Spatial statistics; HEALTH; DISPARITIES; PESTICIDES; MELATONIN; BARRIERS; OBESITY; SERUM;
D O I
10.1016/j.apgeog.2015.04.018
中图分类号
P9 [自然地理学]; K9 [地理];
学科分类号
0705 ; 070501 ;
摘要
This study assessed spatial context and the local impacts of putative factors on the proportion of prostate cancer diagnosed at late-stages in Florida during the period 2001-2007. A logistic regression was performed aspatially and by geographically-weighted regression (GWR) at the nodes of a 5 km spacing grid overlaid over Florida and using all the cancer cases within a radius of 125 km of each node. Variables associated significantly with high percentages of late-stage prostate cancer included having comorbidities, smoking, being Black and living in census tracts with farmhouses. Having private or public insurance, being married or diagnosed in a for-profit facility, as well as living in census tracts with high household income reduced significantly this likelihood. Geographically-weighted regression allowed the identification of areas where the local odds ratio is significantly different from the ratio estimated using aspatial regression (State-level). For example, the local odds ratios for the comorbidity covariates were significantly smaller than the State-level odds ratio in Tallahassee and Pensacola, while they were significantly larger in Palm Beach. This emphasizes the need for local strategies and cancer control interventions to reduce the percentage of prostate cancer diagnosed at late-stages and ultimately eliminate health disparities. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:191 / 200
页数:10
相关论文
共 50 条
  • [31] Racial disparities in late-stage prostate cancer: A SEER database analysis 2005-2015.
    Lin, Jianqing
    Rodriguez, Stephanie
    Zhou, Hanbing
    Sparks, Andrew D.
    Simmens, Samuel J.
    Amdur, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [32] Socioeconomic factors associated with a late-stage pancreatic cancer diagnosis: An analysis of the national cancer database.
    Gallegos, Jillian Marie
    Verplancke, Kiana
    Taylor, Alexandra
    McMahon, Kevin
    Silberstein, Peter T.
    Dahl, Mary Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [33] LATE-STAGE CANCER DIAGNOSIS AND SYSTEMIC THERAPY IN ENGLAND SINCE 2018
    Arocha, Selle L.
    Beattie, A.
    Mitchell, G.
    Robinson, D. E.
    Pearson-Stuttard, J.
    Bray, B. D.
    VALUE IN HEALTH, 2023, 26 (12) : S248 - S248
  • [34] Access and late-stage diagnosis of breast cancer in the military health system
    Bibb, SC
    MILITARY MEDICINE, 2000, 165 (08) : 585 - 590
  • [35] A Matter Of Race: Early-Versus Late-Stage Cancer Diagnosis
    Virnig, Beth A.
    Baxter, Nancy N.
    Habermann, Elizabeth B.
    Feldman, Roger D.
    Bradley, Cathy J.
    HEALTH AFFAIRS, 2009, 28 (01) : 160 - 168
  • [36] Late-stage breast cancer diagnosis and health care access in illinois
    Wang, Fahui
    McLafferty, Sara
    Escamilla, Veronica
    Luo, Lan
    PROFESSIONAL GEOGRAPHER, 2008, 60 (01): : 54 - 69
  • [37] Modeling Geospatial Patterns of Late-Stage Diagnosis of Breast Cancer in the US
    Mobley, Lee R.
    Kuo, Tzy-Mey
    Scott, Lia
    Rutherford, Yamisha
    Bose, Srimoyee
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2017, 14 (05)
  • [38] Socioeconomic factors associated with a late-stage multiple myeloma diagnosis: An analysis of the National Cancer Database
    Patel, Chirag
    Townley, Liam P.
    Silberstein, Peter T.
    Gallegos, Jillian Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [39] Black-white differences in survival from late-stage prostate cancer
    Polednak, AP
    ETHNICITY & DISEASE, 2003, 13 (02) : 220 - 225
  • [40] AML drug improves QOL in late-stage, refractory prostate cancer patients
    不详
    FORMULARY, 1996, 31 (08) : 654 - 654